Waters Corporation (WAT) — Fair Value Analysis

Base-case fair value (P50): $413.32 · Current price: $379.29 · Verdict: Fairly Valued

The Verdict on WAT

Waters Corporation (WAT), operating within the Healthcare sector, is currently assessed as fairly valued according to our Monte Carlo simulations. The company's present share price of $379.29 registers below our median fair value (P50) of $413.32, implying a potential +9.0% upside. This indicates that WAT is not presently overvalued, with the market largely aligning its valuation with our model's intrinsic value projections. This balanced assessment, derived from thousands of forward-looking scenarios, suggests that the stock is trading close to its calculated true worth, offering limited immediate valuation-driven arbitrage opportunities.

How WAT stacks up against Healthcare

Despite the modest +9.0% potential to its median fair value, Waters Corporation's overall operational and financial health is categorized as weak when benchmarked against its Healthcare sector peers. This weak quality tier signals underlying vulnerabilities that could influence its performance across various market cycles, even if the current price of $379.29 is deemed fairly valued. While our Monte Carlo simulation integrates a wide spectrum of potential outcomes, the weak quality tier introduces a layer of caution, prompting investors to consider WAT's fundamental strength relative to more robust companies within the competitive Healthcare landscape. The P50 of $413.32 reflects this comprehensive view.

What this means for investors

For investors, WAT's designation as fairly valued, coupled with a +9.0% to the P50 fair value of $413.32, suggests that significant valuation-based alpha may be limited in the short term. The weak quality tier further tempers expectations, implying that even optimistic bull-case scenarios could face constraints from operational headwinds, potentially capping upside or amplifying downside risks from the current $379.29. FairCurve's advanced Monte Carlo analysis provides this granular, probabilistic view. To fully understand the complete distribution of potential outcomes, including the P10 bear case and P90 bull case, and to track WAT's fair value as new fundamentals are released, sign up for a free FairCurve account.